RayzeBio, Inc. (RYZB) Misses Q3 EPS by 57c

RayzeBio, Inc. (NASDAQ: RYZB) reported Q3 EPS of ($1.26), $0.57 worse than the analyst estimate of ($0.69).

For earnings history and earnings-related data on RayzeBio, Inc. (RYZB) click here.

You May Also Be Interested In

• Solstice acquiring Element Solutions in $14.5B cash and stock deal
• S&P Global releases recast financials after Mobility spin-off
• Morgan Stanley Downgrades Seven & i Holdings Co Ltd (3382:JP) (SVNDF) to Equalweight, Earnings US May Peak F2/27